Achieving Targeted Treatment Outcomes in IBD - Episode 1

Treat-to-target in Inflammatory Bowel Disease

Published on: June 10, 2024

Silvio Danese, MD, PhD , Bruce Sands, MD , Jean-Frederic Colombel, MD

Medical experts in inflammatory bowel disease (IBD) define the concept of "treat-to-target" within the context of IBD and provide current recommendations on treatment targets for ulcerative colitis and Crohn's disease, the two main forms of IBD.

Now Viewing

EP. 1: Treat-to-target in Inflammatory Bowel Disease

EP. 3: Transmural Healing and Monitoring in Ulcerative Colitis and Crohn’s Disease

EP. 4: Implementing Treat to Target in the Long-term in Inflammatory Bowel Disease

EP. 5: Suboptimal Treatment of Inflammatory Bowel Disease in Clinical Practice

EP. 6: Unmet Needs and Starting Advanced Treatment in Inflammatory Bowel Disease

EP. 7: Considerations for Choosing Advanced Treatments and Setting Patient Expectations

EP. 8: Combination Therapy in Inflammatory Bowel Disease

EP. 9: Measuring Patient Satisfaction with Inflammatory Bowel Disease Treatments and Communication Regarding Treatment Changes

What does treat-to-target (t2t) mean in IBD?
1. Is t2t the starting point for disease modification?
What are the recommended treatment targets for IBD? How do they vary between UC and CD?